Boston Angel Investors →
XSITE 2013 →
Founder and CEO, Lighter Capital
President and CEO, NPS Pharmaceuticals
Partner, Latham & Watkins
Prof., Molecular Biology and Chemistry, Scripps Research Institute
President and CEO, Hudson-Webber Foundation
Alnylam and Tekmira are conducting research to find new ways to deliver RNA-interference drugs.
Boston · 6/19/139:00 am
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.
© 2007-2013, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.